Clinical decision support systems by Beeler, Patrick Emanuel et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2014
Clinical decision support systems
Beeler, Patrick Emanuel; Bates, David Westfall; Hug, Balthasar Luzius
Abstract: Clinical decision support (CDS) systems link patient data with an electronic knowledge base in
order to improve decision-making and computerised physician order entry (CPOE) is a requirement to set
up electronic CDS. The medical informatics literature suggests categorising CDS tools into medication
dosing support, order facilitators, point-of-care alerts and reminders, relevant information display, expert
systems and workflow support. To date, CDS has particularly been recognised for improving processes.
CDS successfully fostered prevention of deep-vein thrombosis, improved adherence to guidelines, increased
the use of vaccinations, and decreased the rate of serious medication errors. However, CDS may introduce
errors, and therefore the term ”e-iatrogenesis” has been proposed to address unintended consequences. At
least two studies reported severe treatment delays due to CPOE and CDS. In addition, the phenomenon
of ”alert fatigue” - arising from a high number of CDS alerts of low clinical significance - may facilitate
overriding of potentially critical notifications. The implementation of CDS needs to be carefully planned,
CDS interventions should be thoroughly examined in pilot wards only, and then stepwise introduced.
A crucial feature of CPOE in combination with CDS is speed, since time consumption has been found
to be a major factor determining failure. In the near future, the specificity of alerts will be improved,
notifications will be prioritised and offer detailed advice, customisation of CDS will play an increasing
role, and finally, CDS is heading for patient-centred decision support. The most important research
question remains whether CDS is able to improve patient outcomes beyond processes.
DOI: https://doi.org/10.4414/smw.2014.14073
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-122774
Published Version
 
 
Originally published at:
Beeler, Patrick Emanuel; Bates, David Westfall; Hug, Balthasar Luzius (2014). Clinical decision support
systems. Swiss Medical Weekly, 144:w14073.
DOI: https://doi.org/10.4414/smw.2014.14073
Review article: Medical intelligence | Published 23 December 2014, doi:10.4414/smw.2014.14073
Cite this as: Swiss Med Wkly. 2014;144:w14073
Clinical decision support systems
Patrick Emanuel Beelera,b,c, David Westfall Batesb,d, Balthasar Luzius Huge
a Division of General Internal Medicine & Primary Care, Brigham and Women’s Hospital, Boston, MA, USA
b Harvard Medical School, Boston, MA, USA
c Research Center for Medical Informatics, University Hospital Zurich, Switzerland
d Partners Healthcare Systems, Inc., Wellesley, MA, USA
e Basel University Hospital, Switzerland
Summary
Clinical decision support (CDS) systems link patient data
with an electronic knowledge base in order to improve
decision-making and computerised physician order entry
(CPOE) is a requirement to set up electronic CDS. The
medical informatics literature suggests categorising CDS
tools into medication dosing support, order facilitators,
point-of-care alerts and reminders, relevant information
display, expert systems and workflow support. To date,
CDS has particularly been recognised for improving pro-
cesses. CDS successfully fostered prevention of deep-vein
thrombosis, improved adherence to guidelines, increased
the use of vaccinations, and decreased the rate of serious
medication errors. However, CDS may introduce errors,
and therefore the term “e-iatrogenesis” has been proposed
to address unintended consequences. At least two studies
reported severe treatment delays due to CPOE and CDS.
In addition, the phenomenon of “alert fatigue” – arising
from a high number of CDS alerts of low clinical signific-
ance – may facilitate overriding of potentially critical no-
tifications. The implementation of CDS needs to be care-
fully planned, CDS interventions should be thoroughly ex-
amined in pilot wards only, and then stepwise introduced.
A crucial feature of CPOE in combination with CDS is
speed, since time consumption has been found to be a ma-
jor factor determining failure. In the near future, the speci-
ficity of alerts will be improved, notifications will be pri-
oritised and offer detailed advice, customisation of CDS
will play an increasing role, and finally, CDS is heading
for patient-centred decision support. The most important
research question remains whether CDS is able to improve
patient outcomes beyond processes.
Key words: decision support systems; clinical; health IT;
medicine
Introduction
The volume, complexity and dynamics of clinical inform-
ation are a challenge for physicians and other health pro-
fessionals. Clinical decision support (CDS) systems help
to tackle this challenge. A CDS system links patient data
with a knowledge base to generate information and sugges-
tions that help providers improve the health care they deliv-
er [1–3]. A knowledge base is a database that stores know-
ledge in a suitable form depending on its use [4].
There are several definitions of CDS in the literature show-
ing the wide range of functionality included in these sys-
tems. Shortliffe defined CDS in the following words: “A
medical decision-support system is any computer pro-
gramme designed to help health professionals make clinic-
al decisions” [5]. According to Sim et al. CDS is defined
as “software that is designed to be a direct aid to clinical
decision-making, in which the characteristics of an indi-
vidual patient are matched to a computerised clinical
knowledge base and patient-specific assessments or recom-
mendations are then presented to the clinician or the patient
for a decision” [2].
Computerised physician order entry (CPOE) means that
physicians order online – and it is linked with CDS. The
combination of CPOE and CDS has proven to be very ef-
fective for reducing the frequency of potential adverse drug
events [6].
Technically, CDS software incorporates the generic steps
input, processing, and output: (i.) The patient-specific data
are entered by health professionals involved in the care,
(ii.) processed and linked to knowledge stored in a data
base, and (iii.) notifications are communicated back to the
clinicians [7].
CDS approaches pursuing various objectives have been de-
veloped and evaluated [8]. For instance, CDS successfully
fostered the prevention of deep-vein thrombosis [9], im-
proved the adherence to glucose regulation guidelines for
critically ill patients [10], increased the use of vaccinations
and other preventive measures [11], significantly decreased
the rate of serious medication errors [6], and one system
identified drug-induced thrombocytopenia in an intensive
care unit [12].
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CDS types and functions
Basic actions of CDS systems include alerting, reminding,
critiquing (rejecting orders), interpreting, predicting, dia-
gnosing, assisting and suggesting [13, 14].
Shortliffe distinguished three basic CDS types: (i.) CDS
for information management to provide information on pa-
tients or medical knowledge, (ii.) focusing attention such
as alerts, and (iii.) patient-specific consultation in order to
receive recommendations and customised information on a
single patient [5]. More than twenty years later Wright et
al. [15] studied and summarised CDS taxonomies and cat-
egorised them into the following six types: (i.) “medication
dosing support”, (ii.) “order facilitators”, (iii.) “point-of-
care alerts/reminders”, (iv.) “relevant information display”,
(v.) “expert systems”, and (vi.) “workflow support” (see
table 1). Furthermore, these authors discriminated front-
end and back-end capabilities in CDS. Front-end capabilit-
ies in CDS are described as “intervention types available to
end-users created using specific clinical knowledge bases
and application logic” such as drug-drug interaction
checks, whereas back-end capabilities are summarised as
“discrete system capabilities such as alert triggers, avail-
able data input elements, and end-user notification meth-
ods” [15].
Wright et al. [15] described “medication dosing support”
as tools that support drug order decisions such as choosing
a dose while adjusting it to the patient’s renal and hepatic
functions. “Order facilitators” support the ordering phys-
ician in offering templates with order sets, such as for
the diagnosis and treatment of myocardial infarctions or
common daily drug orders. “Point-of-care alerts/remind-
ers” may show a drug-drug interaction, remind the ordering
physician of a due HbA1c check in a diabetic patient or
alert health staff of critical laboratory values. “Relevant in-
formation display” may show patient specific information
such as showing potassium levels when ordering digox-
in, displaying relevant information such as renal and hep-
atic function as well as body surface area when ordering
chemotherapy and sporting cost of drugs and laboratory
tests. “Expert systems” support physicians by offering
complex decision support combining patient characteristics
with other electronically available data. Examples are dif-
ferential diagnostic suggestions, antibiotic therapy sugges-
tions and prognostic models. “Workflow support” encom-
passes tools such as process templates such as for patients
being transferred to the intensive care unit or medication
reconciliation functions [15].
Impact of CDS
Excellent decisions due to CDS are expected to lead to
higher patient safety with better treatment quality, less ad-
verse events and reduced costs.
There are many different applications that support clinical
physician decisions and a few have been found to improve
outcomes. For instance, a recent study by Bourgeois et al.
presented a CDS intervention for acute respiratory illnesses
in children which reduced antibiotic use, although the net
impact was modest [16]. Furthermore, CDS may improve
patient safety and especially reduce serious medication er-
rors [17]. This is of particular importance, since three out
of four adverse drug events (ADEs) have been shown to be
preventable, and ADEs are common in tertiary referral hos-
pitals as well as in community hospitals [18]. A review by
Wolfstadt et al. mentions that 50% of the identified stud-
ies showed that CPOE combined with CDS reduces the in-
cidence of ADEs significantly [19]. Similar results were
published by Kaushal et al. showing that CDS can reduce
medication error rates substantially [20]. In a survey of six
community hospitals in the greater Boston area, 9 out of 10
adverse drug events were preventable and all of these could
potentially have been prevented with a CDS system includ-
ing renal dose checking [21]. Furthermore, recommended
therapies are being followed, if the information is delivered
at the point of care and no physician response is needed [8].
There is good evidence that CDS improves performance
around prevention [8]. As an example, CDS systems that
alert physicians regarding the need for venous thromboem-
bolism prophylaxis have proven to be very successful. The
study by Kucher at al. showed a significant reduction of
symptomatic and asymptomatic deep-vein thrombosis due
to CDS alerts [9]. Others found that (i.) electronic throm-
boprophylaxis reminders have a sustained effect [22, 23],
(ii.) reminders after both admissions and transfers have a
significant impact on the awareness of thromboembolism
prevention [24], and (iii.) the timing of CDS needs to be ad-
dressed in order to thoroughly evaluate such interventions
[22, 24].
Alerts should provide knowledge gain without too many
workflow interruptions. Otherwise they may cause “alert
fatigue” (cf. next chapter),regarding drug-drug interactions
for example [25], without reaching any patient safety goals
[26]. Wipfli and Lovis discussed points to consider design-
ing and installing alerts [27].
Some aspects of CDS impact need additional assessment.
There is still insufficient data on the influence of CDS
on management of patients with multiple chronic diseases,
clinician workload, length of stay of hospitalised patients,
Table 1: Overview of CDS types and functions, adapted from Wright et al. [15].
CDS type Examples
1. “Medication Dosing support” Suggests routine dosages as well as dose reductions in patients with loss of renal function.
2. “Order facilitators” Template for admission orders in pneumonia and order sets.
3. “Point-of-care alerts/reminders” Shows drug-drug interactions, warns against too high levels of potassium, and reminds of intravenous to oral switch of
antibiotics.
4. “Relevant information display” Offers potassium level when ordering digoxin, renal and hepatic functions display, and body surface when ordering
chemotherapy.
5. “Expert systems” Diagnostic and treatment decision support and planning, e.g. suggestion of an antibiotic therapy in consideration of blood
culture results and local bacterial resistance patterns.
6. “Workflow support” Medication reconciliation of current drug therapies in patients transferred, admitted or discharged.
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mortality and economic impact, warranting further studies
in these and other areas [8, 28].
Potential harms
The Institute of Medicine’s book “To Err is Human” [29]
advocated the use of CPOE in combination with CDS to
increase patient safety. However, it is clear that health in-
formation technology can also create new safety issues and
some have expressed doubts about whether CDS improves
patient outcomes [30–32] – we believe that it does, but its
impact varies substantially by content domain, and it does
not necessarily produce improvements in any specific area.
Koppel et al. [33] identified and observed 22 situations
where CPOE facilitated medication errors, such as mislead-
ing display of dose ranges. As a consequence the authors
suggested to (i.) emphasise workflow more than CPOE in
reducing medication risks, (ii.) evaluate the implemented
CPOE system, (iii.) fix CPOE problems as soon as pos-
sible, (iv.) consider and investigate various causes of med-
ication errors, and (v.) progressively improve quality while
“recognising that all changes generate new error risks”
[33].
An article published by Han et al. [34] reported a signific-
ant increase in the mortality of children after a commer-
cial CPOE system had been implemented (adjusted odds
ratio 3.28). In essence, the authors explained the increased
mortality by delayed administration of critical medications
due to mal-performance of the CPOE system – which ap-
parently required an additional physician solely entering
orders, led to complicated communication between health
professionals, and decreased the time of physicians and
nurses at the bedside [34].
That publication raised a number of comments: Some read-
ers acknowledged the importance of this contribution to the
literature in the field, but also, they recommended to care-
fully plan CPOE and CDS implementations as well as thor-
oughly examine systems and functions only in pilot wards,
before stepwise introducing them [31, 35, 36]. One group
highlighted the reported policy changes (removal of crucial
drugs from location of care, interdiction of prescribing be-
fore patient’s arrival, pharmacy received orders not before
approval by a nurse) contributing to critical administration
delays, which were independent of the technology [37].
Changing the policies during or shortly before a CPOE
implementation process should be avoided [36]. However,
the reportedly inadequate performance of the network and
CPOE system, and the missed preparation of electronic or-
der sets have been criticised [35, 37]. The latter was one of
the most serious omissions in the view of Jacobs et al. (38),
and this group also emphasised that – as long as the phar-
macist accessed the electronic patient chart – other health
professionals were “locked out,” [34] in that they were un-
able to enter additional orders.
Furthermore, some commentators highlighted that the im-
plementation of computerisation in the clinical setting is
complex and inevitably changes the workflows [35, 36].
However, it is crucial that health professionals are always
able to care for the patient, including the possibility of us-
ing paper orders [35, 36]. It has been stated that it is un-
reasonable to implement CPOE in only six days [31, 35]
as described [34]. In contrast, such implementations have
been estimated to require from 1 to 3 years [36, 39]. Fin-
ally, Han et al. [40], among many others including the In-
stitute of Medicine, suggested establishing an independent
board that ensures the safety of health information techno-
logy (HIT), similar to safety arrangements in the aviation
industry [36], and in fact, such a group is now being set up
in the U.S.
Another group [41] observed and interviewed health pro-
fessionals of five U.S. hospitals and identified a large num-
ber of issues due to CPOE and particularly CDS, including
additional workload and too many false positive alerts. As
a consequence, Weiner et al. [42] introduced the term “e-
iatrogenesis”.
False positive alerts increase the risk of alert fatigue [25].
This psychological phenomenon results from high numbers
of clinically insignificant alerts that consume time and
mental energy, potentially causing overrides of highly im-
portant notifications [43]. However, by increasing the spe-
cificity of electronic notifications, the risk of alert fatigue
will be minimised. For instance, Hulgan et al. [44] presen-
ted a sophisticated algorithm that detected drip-fed patients
– before electronically suggesting the oral route for intra-
venous quinolones.
Strom et al. [45] evaluated interruptive alerts in a ran-
domised controlled trial: The aim of the CDS intervention
was to avoid a potentially harmful drug-drug interaction
between warfarin and trimethoprim-sulfamethoxazole. It
was possible to override these hard-stop alerts (i) by enter-
ing the indication would be Pneumocystis carinii pneumo-
nia or (ii) by calling the pharmacy. On the one hand, the
intervention had a significant impact on prescription beha-
viour, but on the other hand, the institutional review board
terminated the study early because of inacceptable treat-
ment delays in four patients due to the interruptive alerts.
A high proportion of all known drug interactions are of low
clinical significance [43]. Not so the interaction between
warfarin and trimethoprim-sulfamethoxazole, which in-
creases the bleeding risk substantially [46]. Strom et al.
[45] implemented a strong CDS intervention, though, re-
gardless of whether the patients were already stabilised on
warfarin (adding trimethoprim-sulfamethoxazole increases
bleeding risk), or whether they already received
trimethoprim-sulfamethoxazole and warfarin administra-
tion was initiated (little risk for bleeding) [47]. Horn con-
cluded that “a reminder to appropriately monitor the pa-
tient’s INR would have mitigated the risk of the interaction
while avoiding the unintended consequences” [47].
However, a hard-stop alert may not be the best option to
avoid the outlined drug-drug interaction, because there are
patients who urgently need both drugs – whereas absolute
contraindications (e.g. isotretinoin during pregnancy) war-
rant strong interventions [48].
Implementation of CDS: points to
consider
Computerised CDS has been investigated for several dec-
ades [49, 50]. The trend away from the “Greek oracle” ap-
proach of diagnostic decision support systems to a more
supporting kind of software was accompanied by improv-
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ing hardware and philosophical changes regarding the
human-computer interaction (the physician outgrew the
role of a passive observer) [50]. More recently, it has been
realised that the way CDS is implemented and presented is
critical for a system to succeed (see table 2), and that time
consumption is a major factor determining failure [51].
Kawamoto et al. [52] analysed publications on electronic
and non-electronic decision support systems and presented
four CDS features that contributed to improved clinical
practice: (i) “provide decision support automatically as part
of clinician workflow”, (ii) “deliver decision support at the
time and location of decision making”, (iii) “provide ac-
tionable recommendations”, and (iv) “use a computer to
generate the decision support”.
Notifications should be specific and fit the context when
displayed, in order to minimise overriding [25]. However,
besides patient-specificity, physician-related factors should
also be considered while designing interventions [53], and
the understanding of human factors have been recognised
to be important to the acceptance of CDS [54]. Software
needs to be tailored to suit the users of different target
groups among health professionals [55].
There is a need for governance when implementing and
employing CDS systems. Wright et al. [56] offer a com-
prehensive summary with six recommendations outlined in
table 3. It is important to realise the impact CDS may have
on clinical practice as well as surrounding clinical expert
systems. Accordingly, a governance concept followed up
on by a group of specialists in clinical as well as technic-
al aspects is warranted. Therefore, Eppenga et al. suggest
evaluating CDS systems repeatedly, in order to review, ad-
just and improve algorithms [57].
Outlook and future research
O’Connor et al. [58] published an overview and outlook
of CDS in diabetes care, and some points discussed in
this article are generalisable to other future CDS devel-
opments. For instance, CDS should suggest therapeutic
options whenever it warns against problems, individual
customisation of CDS will play an increasing role, CDS
should be designed to save time, and CDS is moving to-
ward patient-centred decision support [58]. In fact, CDS
directed not only to health professionals but also to the pa-
tient seems to be a powerful approach as concluded in two
recent meta-analyses [59, 60]. This is an important result
that needs to be considered while developing novel CDS
interventions.
Furthermore, O’Connor et al. hope that – within the next 10
years – the compatibility issues across different electron-
ic health records will be solved, CDS implementations will
provide “validated transparent clinical algorithms”, CDS
will be able to prioritise recommendations, and genetic
markers will be part of the input data considered by the sys-
tems [58].
Features identified to be crucial in successful CDS inter-
ventions are “provide decision support automatically as
part of clinician workflow”, “deliver decision support at
the time and location of decision making”, “provide action-
able recommendations”, “use a computer to generate the
decision support” [52], and “integration with charting or
order entry system, promotion of action rather than inac-
tion, no need for additional clinician data entry, justifica-
tion of decision support via research evidence, local user
Table 3: Governance recommendations for CDS, according to Wright
et al. [56].
Recommendation
1. “Prioritise the order of development for new CDS and delegate
content development to specialised working groups”
2. “Consider the potential impact of new CDS on existing clinical
information systems”
3. “Develop tools to monitor CDS inventory, facilitate updates, and
ensure continuity”
4. “Implement procedures for assessing the impact of changes and
additions to CDS system’s own the system’s own functionality”
5. “Provide multiple robust channels for user feedback and the
dissemination of systems-related information to end users”
6. “Develop tools for ongoing monitoring of CDS interventions“
Table 2: Summary of the 10 commandments for effective clinical decision support by Bates et al. [51].
Commandment Explanation
1 “Speed Is Everything” Speed is the most important feature of a clinical information system.
2 “Anticipate Needs and Deliver in Real Time” Clinical decision support should anticipate needs, e.g. suggest dose adjustments when the
kidney function worsens.
3 “Fit into the User’s Workflow” CDS should be integrated with practice, e.g. displaying prescription recommendations right at
the time when the physician is in the process of ordering the specific drug.
4 “Little Things Can Make a Big Difference” The usability of a system is crucial. CDS should be designed to allow for intuitively working with
the system.
5 “Recognize that Physicians Will Strongly Resist Stopping” Suggestions not to carry out a specific action are frequently ignored by users. Offering
alternatives can help to mitigate this problem, however, monitoring the overrides and face-to-
face conversations may be required.
6 “Changing Direction Is Easier than Stopping” Systems can be designed to lead users in the right direction. For instance, if free text entries
hamper CDS functions, the system should display check boxes providing likely choices, in
addition to the free text field.
7 “Simple Interventions Work Best” Comprehensive guidelines usually don't fit on a single screen. However, computerised guidelines
are more likely to be adopted in routine practice if they display the key points only, on a single
screen.
8 “Ask for Additional Information Only When You Really Need It” CDS has been shown to lose effectiveness if the computer demands additional data input.
9 “Monitor Impact, Get Feedback, and Respond” Over-alerting increases the risk of alert fatigue and important notifications might be ignored.
Therefore, when computerised interventions are implemented they should be evaluated early,
corrected and improved.
10 “Manage and Maintain Your Knowledge-based Systems” It is important to keep the front-end (user interface of CDS) and the back-end (algorithms and
knowledge base) up to date. This process involves the consideration of new medical knowledge.
Review article: Medical intelligence Swiss Med Wkly. 2014;144:w14073
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involvement, and provision of decision support results to
patients as well as providers” [59]. Studies are needed to
prospectively investigate the individual role and import-
ance of these features one by one [59].
It has repeatedly been stated [30–32, 58, 59, 61] that study
results, regarding whether CDS actually improves clinical
outcomes, are still scarce. The limited power of available
studies is an important reason for this knowledge gap [24,
48]. Murphy [61] proposed cohort studies as a means to in-
vestigate the long-term outcomes of CDS on morbidity and
mortality. Quality measures and financial incentives might
additionally boost the meaningful implementation and ef-
fectiveness of CDS [61].
It is likely that knowledge implemented in CDS tools will
be shared more widely in the future, by uploading know-
ledge to repositories, by disclosing the specifications of
algorithms, and by sharing executable modules
(cf. www.opencds.org) [48, 62]. The knowledge manage-
ment of CDS is a novel research field with great promise
[63]. It includes the use of specialised management soft-
ware, considers online tools and online collaborations, the
dissemination of CDS knowledge, and knowledge genera-
tion by data mining.
Hongsermeier et al. [64] mention the need for protection
of intellectual property invested in CDS in order to foster
sharing of CDS knowledge. However, it is difficult to pat-
ent intellectual property of the knowledge integrated in
CDS. Additionally another aspect is that – while health
care providers are considered to be the “learned intermedi-
aries” deciding to follow CDS recommendations or not –
the liability principles in terms of CDS and its developers
are still not well established [65]. Finally, the policies on
premarket review and regulations on CDS are – if not ob-
scure – in progress [66]. A comparison of the CDS reg-
ulations in the U.S. and the E.U. has been published by
Andersson [67].
Implementation of customisation regarding alerts for pro-
viders and regarding information for patients is complex
[68], however, the user profiles of the target groups should
be extended, for example personal options such as ‘‘remind
me in one week’’ and ‘‘don’t show this message again’’
could play a role [55]. Researchers should always consider
the impact of both the back-end (algorithms and knowledge
base) and front-end (user interface) of CDS interventions
[51]. Sophisticated algorithms allow for increasing the spe-
cificity of notifications [44, 69, 70], and in turn, decrease
the risk for alert fatigue [25]. In addition, the design of the
human-computer interface should consider human factors
principles, and the extent to which it does so will affect per-
formance [54, 62, 71].
CDS systems – whether commercial or home-grown – need
to be carefully addressed in an on-going way. There is no
doubt that CDS specialists will increasingly be a wanted
human resource [60]. Furthermore, the more patient-spe-
cific and clinically significant the content of CDS notifica-
tions is, the more users will accept and value computerised
recommendations. CDS works best when providers are led
to make it easy to do the right thing, rather than through ap-
proaches in which – after a lot of ordering work is done –
critiques are provided at the end. Overall, much of the be-
nefit which is realised from electronic health records comes
from the embedded CDS, and it is essential to do a good
job with it.
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